75,250 Shares in Apyx Medical Co. (NASDAQ:APYX) Purchased by RPg Family Wealth Advisory LLC

RPg Family Wealth Advisory LLC acquired a new position in shares of Apyx Medical Co. (NASDAQ:APYX) in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm acquired 75,250 shares of the company’s stock, valued at approximately $101,000. RPg Family Wealth Advisory LLC owned approximately 0.22% of Apyx Medical as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also modified their holdings of the company. Rathbones Group PLC grew its holdings in shares of Apyx Medical by 148.0% during the second quarter. Rathbones Group PLC now owns 251,334 shares of the company’s stock worth $337,000 after buying an additional 150,000 shares in the last quarter. Commonwealth Equity Services LLC grew its holdings in shares of Apyx Medical by 2.9% during the second quarter. Commonwealth Equity Services LLC now owns 511,561 shares of the company’s stock worth $685,000 after buying an additional 14,481 shares in the last quarter. Perkins Capital Management Inc. grew its stake in Apyx Medical by 7.0% in the first quarter. Perkins Capital Management Inc. now owns 228,500 shares of the company’s stock valued at $311,000 after purchasing an additional 15,000 shares in the last quarter. Kingsview Wealth Management LLC grew its stake in Apyx Medical by 156.7% in the first quarter. Kingsview Wealth Management LLC now owns 31,028 shares of the company’s stock valued at $42,000 after purchasing an additional 18,943 shares in the last quarter. Finally, Silverberg Bernstein Capital Management LLC grew its stake in Apyx Medical by 1.2% in the first quarter. Silverberg Bernstein Capital Management LLC now owns 621,387 shares of the company’s stock valued at $845,000 after purchasing an additional 7,507 shares in the last quarter. 55.33% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Separately, JMP Securities restated a “market perform” rating on shares of Apyx Medical in a research note on Monday.

Apyx Medical Stock Up 0.9 %

APYX stock opened at $1.08 on Wednesday. The company has a quick ratio of 4.45, a current ratio of 5.33 and a debt-to-equity ratio of 2.26. The business has a 50 day moving average price of $1.27 and a two-hundred day moving average price of $1.43. The company has a market cap of $37.42 million, a price-to-earnings ratio of -1.64 and a beta of 1.20. Apyx Medical Co. has a twelve month low of $0.97 and a twelve month high of $4.00.

Apyx Medical (NASDAQ:APYX) last posted its quarterly earnings results on Thursday, August 8th. The company reported ($0.19) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.18) by ($0.01). The company had revenue of $12.15 million during the quarter, compared to the consensus estimate of $12.67 million. Apyx Medical had a negative net margin of 57.86% and a negative return on equity of 105.45%. During the same quarter in the prior year, the business earned ($0.11) earnings per share. Analysts anticipate that Apyx Medical Co. will post -0.69 EPS for the current fiscal year.

Apyx Medical Company Profile

Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures.